Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2008-03-25
2008-03-25
Campell, Bruce R. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C435S005000
Reexamination Certificate
active
07348134
ABSTRACT:
A cell-free method for translation and assembly of retroviral, particularly HIV, capsid and capsid intermediates is disclosed. Also disclosed are novel HIV capsid assembly intermediates and novel host proteins which bind to such assembly intermediates. The invention also includes a screening method for compounds that alter retrovirus capsid assembly, and a method of treating HIV using compounds which inhibit the HIV capsid assembly pathway.
REFERENCES:
patent: 5324637 (1994-06-01), Thompson et al.
Niedrig et al. Inhibition of infectious human immunodeficiency virus type 1 particle formation by Gag protein-derived peptides. Journal of General Virology Jun. 1994, vol. 75, No. 6, pp. 1469-1474.
Ebbets-Reed et al. Major homology region of the HIV-1 Gag precursor influences membrane affinity. Biochemistry 1996, vol. 35, pp. 14268-14275.
Bryant et al. Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containg analogs of myric acid. Proceedings from National Academy of Science, USA Nov. 1989, vol. 86, p. 8655-8659.
Bisbal et al.,J. Biol. Chem. 270 (22): 13308-133 17 (1995).
Lingappa et al.,J. Cell Biol. 125 (1): 99-111 (1994).
Lingappa et al.,J. Cell Biology136: 567-581 (1997).
Sakalian et al.,J. Virology70: 3706-3715 (1996).
Spearman et al.,J. Virology70 (11): 8187-8194 (1996).
Weldon et al.,J. Virology72: 3098-3106 (1998).
Lehninger et al.,Principles of Biochemistry2ndEd.: 483-485 (1993).
Platt et al.,Proceedings of the NAS91: 4594-4598 (1994).
Geballe et al.,Nucleic Acid Research20: 4291-4297 (1992).
Raju et al.,Molecular and Cellular Biochemistry149/150: 191-202 (1995).
Carmichael, “Silencing Viruses with RNA”.Nature 418: 379-380 (2002).
Degar, S., et al., “Inactivation of the Human Immunodeficiency Virus by Hypericin: Evidence for Photochemical Alterations of p24 and a Block in Uncoating”.AIDS Res. Hum. Retroviruses 8(11): 1929-1936 (1992).
Erickson and Blobel, “Cell-Free Translation of Messenger RNA in a Wheat Germ System”.Enzymol. 96: 38-50 (1983).
Facke, M., et al., “A Large Deletion in the Matrix Domain of the Human Immunodeficiency VirusgagGene Redirects Virus Particle Assembly from the Plasma Membrane to the Endoplasmic Reticulum”.J. Virology 67: 4972-4980 (1993).
Flores, et al., “Akt-Mediated Survival of Oligodendrocytes Induced by Neuregulins”.J. Neuroscience 20: 7622-30 (2000).
Gelderblom, H.R., “Assembly and Morphology of HIV: Potential Effect of Structure on Viral Function”.AIDS 5: 617-638 (1991).
Gheysen, D., et al., “Assembly and Release of HIV-1 Precursor Pr55gagVirus-Like Particles from Recombinant Baculovirus-Infected Insect Cells”.Cell 59: 103-112 (1989).
Glass, J.D., “A Sequence Related to the Human Gonadoliberin Precursor Near the N-terminal of HIV and SIVgagPolyproteins”.J. Theor. Biol. 150(4): 489-496 (1991).
Goncalves, et al., “Functional Neutralization of HIV-1 Vif Protein by Intracellular Immunization Inhibits Reverse Transcription and Viral Replication”.J. Biol. Chem. 277: 3206-3205 (2002).
Gorlich, et al., “A Protein of the Endoplasmic Reticulum Involved Early in Polypeptide Translocation”.Nature 357:47-52 (1992).
Gottlinger, H.G., et al., “Role of Capsid Precursor Processing and Myristoylation in Morphogenesis and Infectivity of Human Immunodeficiency Virus Type 1”.Proc. Natl. Acad. Sci. 86: 5781-5785 (1989).
Hegde, et al., “Regulation of Protein Topology bytrans-Acting Factors at the Endoplasmic Reticulum”.Molecular Cell 2: 85-89 (1998).
Hockley, D.J., et al., “Comparative Morphology of Gag Protein Structures Produced by Mutants of theGagGene of Human Immunodeficiency Virus Type 1”.J. Gen. Virology 75: 2985-2997 (1994).
Isada C., “New Developments in Long-Term Treatment of HIV: The Honeymoon is Over”.Cleve Clin. J. Med. 68: 804-7 (2001).
Jain, et al., “Metabolic Complications Associated with Antiretroviral Therapy”.Antiviral Res. 51: 151-77 (2001).
Jowett, J.B.M., et al., “Distinct Signals in Human Immunodeficiency Virus Type 1 Pr55 Necessary for RNA Binding and Particle Formation”.J. Gen Virology 73: 3079-3086 (1992).
Kaushik, N., et al., “Role of Glutamine-151 of Human Immunodeficiency Virus Type-1 Reverse Transcriptase in RNA-Directed DNA Synthesis”.Biochemistry 36(47): 14430-14438 (1997).
Laughrea, M., et al., “Mutations in the Kissing-Loop Hairpin of Human Immunodefficiency Virus Type 1 Reduce Viral Infectivity as Well as Genomic RNA Packaging and Dimerization”.J. Virology 71(5): 3397-3406 (1997).
Li, Z., et al., “Multiple Forms of tRNALys3in HIV-1”.Biochem. Biophys. Res. Commun. 227(2): 530-540 (1996).
Lin and Keeffe, “Current Treatment Strategies for Chronic Hepatitis B and C”.Annu. Rev. Med. 52: 29-49 (2001).
Lo, et al., “Interaction Between Hepatitis C Viruse Core Protein and E1 Envelope Protein”.J. Virology 70: 5177-82 (1996).
Merrick, W. C., “Translation of Exogenous mRNAs in Reticulocyte Lysates”.Methods Enzymol. 101: 606-615 (1983).
Morris, et al., “A Peptide Carrier for the Delivery of Biologically Active Proteins into Mammalian Cells”.Nature Biotechnology 19: 1173-1176 (2001).
Novina, et al., “siRNA-Directed Inhibition of HIV-1 Infection”.Nature Medicine 8: 681-686 (2002).
Ohlmann, T., et al., “An Internal Ribosome Entry Segment Promotes-Translation of the Simian Immunodeficiency Virus Genomic RNA”.J. Biol. Chem. 275(16): 11899-906 (2000).
Ou, et al., “Preferred Translation of Human Hepatitis B Virus Polymerase from Core Protein-but Not From Precore Protein-Specific Transcript”.J. Virology 64(9): 4578-4581 (1990).
Page, K. A., et al., “Construction and Use of a Human Immunodeficiency Virus Vector for Analysis of Virus Infectivity”.J. Virology 64(11): 5270-5276 (1990).
Papadopulos-Eleopulos, et al., “A Critical Analysis of the Pharmacology of AZT and its Use in AIDS”.Curr. Med. Res. Opin. Suppl., 1: S1-45 (1999).
Ren, et al., “Caco-2 Cell Permeability vs Human Gastro-Intestinal Absorption: QSPR Analysis”.Prog. Drug Res. Spec. No. 1-34 (2001).
Richards, et al., “Inhibition of the Aspartic Proteinase from HIV-2”.FEBS Lett, 253: 214-216 (1989).
Rose, et al., “Consensus-Degenerate Hybrid Oligonucleotide Primers for Amplification of Distantly Related Seqeunces”.Nucleic Acids Research 26: 1628-1635 (1998).
Royer, M., et al., “Functional Domains of HIV-1gag-Polyprotein Expressed in Baculovirus-Infected Cells”.Virology 184: 417-422 (1991).
Rutkowski, et al., “Substrate-Specific Regulation of the Ribosome-Translocon Junction byN-Terminal Signal Sequences”.PNAS 98: 7823-7828 (2001).
Santolini, et al., “Biosynthesis and Biochemical Properties of the Hepatitis C Virus Core Protein”.J. Virology 68: 3631-41 (1994).
Sen, et al., “The Interferon System: A Bird's Eye View of its Biochemistry”.JBC 267: 5017-20 (1992).
Shih, et al., “Modulation of thetrans-Suppression Activity of Hepatitis C Virus Core Protein by Phosphorylation”,J. Virology 69: 1160-71 (1995).
Smith, K., “To Cure Chronic HIV Infection, a New Therapeutic Strategy is Needed”.Curr. Opin. Immunol. 13: 614-24 (2001).
Spearman, P., et al., “Identification of Human Immunodeficiency Virus Type 1 Gag Protein Domains Essential to Membrane Binding and Particle Assembly”.J. Virology 68: 3232-3242 (1994).
Spirin, et al., “A Continuous Cell-Free Translation System Capable of Producing Polypeptides in High Yield”.Science 242: 1162-1164 (1988).
Tanchou, V., et al., “Formation of Stable and Functional HIV-1 Nucleoprotein Complexes in Vitro”.J. Mol. Biol. 252(5): 563-571 (1995).
Towler, D.A., et al., “The Biology and Enzymology of Eukaryotic Protein Acylation”.Ann. Rev. Bioche
Lingappa Jaisri R.
Lingappa Vishwanath R.
Campell Bruce R.
Humphrey Louise
Quine Intellectual Property Law Group P.C.
The Regents of the University of California
LandOfFree
HIV capsid assembly-associated compositions and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HIV capsid assembly-associated compositions and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV capsid assembly-associated compositions and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2786614